Thesis Abstract

**Abstract
** Cancer remains one of the leading causes of death worldwide, with conventional treatments often associated with significant side effects due to their non-specific nature. Nanotechnology has emerged as a promising approach for targeted drug delivery in cancer treatment, offering the potential to enhance therapeutic efficacy while minimizing adverse effects. This thesis investigates the application of nanotechnology in targeted drug delivery for cancer treatment, with a focus on addressing the limitations of current treatment modalities. The study begins with a comprehensive review of the background of nanotechnology in drug delivery, highlighting its potential benefits in improving treatment outcomes for cancer patients. The problem statement underscores the urgent need for more effective and targeted therapies to combat cancer while minimizing harm to healthy tissues. The objectives of the study include evaluating the effectiveness of nanotechnology-based drug delivery systems in delivering anticancer agents specifically to tumor sites, as well as assessing their overall impact on treatment outcomes. Limitations of the study are acknowledged, including the complexities of nanotechnology-based drug delivery systems and challenges related to their clinical translation. The scope of the study encompasses various types of nanocarriers and targeting strategies employed in cancer treatment, aiming to provide a comprehensive analysis of current developments in the field. The significance of the study lies in its potential to contribute to the advancement of personalized and targeted cancer therapies, ultimately improving patient outcomes and quality of life. The structure of the thesis is outlined, detailing the organization of chapters and key components of each section. Definitions of essential terms related to nanotechnology, drug delivery, and cancer treatment are provided to ensure clarity and understanding throughout the thesis. Chapter two presents a detailed literature review, covering ten key aspects of nanotechnology-based drug delivery in cancer treatment. This section synthesizes existing knowledge and research findings to provide a comprehensive overview of the current state of the field, identifying gaps and opportunities for further investigation. Chapter three focuses on the research methodology employed in this study, including experimental design, data collection methods, and analytical approaches. Eight key components are detailed, outlining the steps taken to evaluate the effectiveness and feasibility of nanotechnology-based drug delivery systems in cancer treatment. Chapter four presents a thorough discussion of the findings obtained from the study, including the efficacy of various nanocarriers, targeting strategies, and drug formulations in delivering anticancer agents to tumor sites. This section critically analyzes the results and their implications for future research and clinical applications. Finally, chapter five provides a conclusion and summary of the thesis, highlighting the key findings, implications, and recommendations for future research in the field of nanotechnology for targeted drug delivery in cancer treatment. This section encapsulates the significance of the study and its potential impact on advancing personalized and effective cancer therapies.

Thesis Overview